No abstract available
Keywords:
FDG; atherosclerosis; immune checkpoint inhibitor therapy; inflammation; positron emission tomography.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Aorta / diagnostic imaging
-
Aorta / drug effects*
-
Aorta / immunology
-
Arteritis / chemically induced*
-
Arteritis / diagnostic imaging
-
Arteritis / immunology
-
CTLA-4 Antigen / antagonists & inhibitors
-
Female
-
Fluorodeoxyglucose F18
-
Humans
-
Iliac Artery / diagnostic imaging
-
Iliac Artery / drug effects*
-
Iliac Artery / immunology
-
Immune Checkpoint Inhibitors / adverse effects*
-
Immunity, Innate / drug effects
-
Male
-
Melanoma / drug therapy*
-
Melanoma / immunology
-
Melanoma / pathology
-
Middle Aged
-
Neoplasm Staging
-
Positron Emission Tomography Computed Tomography
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
Radiopharmaceuticals
-
Retrospective Studies
-
Risk Factors
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / immunology
-
Skin Neoplasms / pathology
Substances
-
CTLA-4 Antigen
-
CTLA4 protein, human
-
Immune Checkpoint Inhibitors
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18